Below is Validea's guru fundamental report for BIONTECH SE - ADR (BNTX). Of the 22 guru strategies we follow, BNTX rates highest using our Value Investor model based on the published strategy of ...

BioNTech SE (NASDAQ:BNTX – Free Report) – Research analysts at HC Wainwright increased their Q1 2025 earnings estimates for shares of BioNTech in a note issued to investors on Tuesday ...

Vetter, Chairman of the Supervisory Board of ITM. " The expansion of our Supervisory Board and its insights ensures that ITM ...

Strategic Milestone Achievement and Increased Financial Discipline Underscore Year of Corporate Transformation Completed ...

As a Venture Partner at Third Rock Ventures, she led teams in creating new oncology drug discovery companies, including Tango Therapeutics, Neon Therapeutics (acquired by BioNTech (Nasdaq ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on Regeneron (REGN – Research Report), with a price ...

Morgan Stanley analyst Terence Flynn maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price target ...

Morgan Stanley analyst Terence Flynn maintained a Hold rating on Amgen (AMGN – Research Report) today and set a price target of $330.00. The ...

We recently published a list of 10 Best Low Priced Growth Stocks To Invest In. In this article, we are going to take a look at where ​​Roivant Sciences Ltd.

The firm grew demand, total head count, and its equity and nonequity partnership tiers, leading to a 27% surge in net income.

Health Secretary Robert F. Kennedy Jr., who has often linked vaccines to the neurodevelopmental disorder autism, said ...

Apogee (NASDAQ:APOG), price target $95. Avidity, price target $70, BioNTech (NASDAQ:BNTX), price target $145. Kiniksa, 89BIO (ETNB) appears to have found support after losing some value lately ...